[1] 黄劬,刘殿阁,宋文娟.2型糖尿病肾病微炎症反应与急性[J].现代医学,2010,38(6):603-606.
[2] TESCH G H,ALLEN T J.Rodent models of streptozotocin-induced diabetic nephropathy[J].As Paci Soc Nephrol,2007,12:261-266.
[3] 李志杰,张悦.糖尿病肾病动物模型的研究进展[J].生命科学,2011,23(1):90-95.
[4] BREYER M D,BOTTINGER E,BROSIUS F C,et al.Mouse models of diabetic nephropathy[J].J Am Soc Nephrol,2005,16:1-19.
[5] ROSSINI A A,APPEL M C,WILLIAMS R M,et al.Genetic influence of the streptozotocin-induced insulitis and hyperglycemia[J].Diabetes,1977,26:916-920.
[6] LEITER E.Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice:influence of inbred background,sex,and thymus[J].Proc Natl Acad Sci USA,1982,79:630-634.
[7] HASEYAMA T,FUJITA T,HIRASAWA F,et al.Complications of IgA nephropathy in a non-insulin-dependent diabetes model,the Akita mouse[J].Tohoku J Exp Med,2002,198:233-244.
[8] SUSZTAK K,RAFF A C,SCHIFFER M,et al.Glucose-induced reactiveoxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy[J].Diabetes,2006,55:225-233.
[9] WATANABE Y,ITOH Y,YOSHIDA F,et al.Unique glomerular lesion with spontaneous lipid deposition in glomerular capillary lumina in the NON strain of mice[J].Nephron,1991,58:210-218.
[10] XU J,HUANG Y,LI F,et al.FVB mouse genotype confers susceptibility to OVE26 diabetic albuminuria[J].Am J Physiol Renal Physiol,2010,299:F487-F494.
[11] REINIGER N,LAU K,MCCALLA D,et al.Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse[J].Diabetes,2010,59:2043-2054.
[12] 李桂云,吴正治.STZ 建立2型糖尿病大鼠模型的剂量探讨[J].深圳中西医结合杂志,2007,17(2):74-77.
[13] UO X H,LIU Z H,LI H,et al.Type 2 diabetes mellitus induced by diets and its features of renal involvement in rat[J].Chin J Diabete,2002,10(5):290-294.
[14] 刘彦君.自发的 2型糖尿病动物模型—OLETF大鼠[J].国外医学:内分泌学分册,1999,19:26-29.
[15] SCHAFER S,LINZ W,BUBE A,et al.Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats[J].Cardiovasc Res,2003,60:447-454.
[16] GASSLER N,ELGER M,KRANZLIN B,et al.Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat[J].Kidney Int,2001,60:106-116.
[17] HIRASAWA Y,MATSUI Y,YAMANE K,et al.Pioglitazone improves obesity type diabetic nephropathy:relation to the mitiggtion of renal oxidative reaction[J].Exp Anim,2008,57(5):423-432.
[18] REISIN E,EBENEZER P J,LIAO J,et al.Effect of the HMG-CoA reductase inhibitor rosuvastatin on early chronic kidney injury in obese Zucker rats fed with an atherogenic diet[J].Am J Med Sci,2009,338(4):301-309.
[19] ALPERS C E,HUDKINS K L.Mouse models of diabetic nephropathy[J].Curr Opin Nephrol Hypertens,2011,20:278-284.
[20] SHARMA K,MCCUE P,DUNN S R.Diabetic kidney disease in the db/db mouse[J].Am J Physiol Renal Physiol,2003,284:F1138-F1144.
[21] CLEE S M,ATTIE A D.The genetic landscape of type 2 diabetes in mice[J].Endocr Rev,2007,28:48-83.
[22] HUDKINS K L,PICHAIWONG W,WIETECHA T,et al.BTBR ob/ob mutant mice model progressive diabetic nephropathy[J].J Am Soc Nephrol,2010,21:1533-1542.
[23] 董哲毅,华参,高翔.2型糖尿病动物模型KK-Ay小鼠糖尿病肾病的鉴定[J].山东医药,2008,13(48):17-19. |
